Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses (Q91566784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

title

Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

Marcelo Pires Amaral

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Juliana de Souza Apostolico

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Nádia Tomita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Fernanda Caroline Coirada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Victória Alves Santos Lunardelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Edgar Ruz Fernandes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Higo Fernando Santos Souza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Renato Mancini Astray

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Silvia Beatriz Boscardin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Daniela Santoro Rosa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

publication date

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

3653-3664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

Zika virus. I. Isolations and serological specificity

23 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

ZIKA VIRUS INFECTION IN MAN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

First published report of Zika virus infection in people: Simpson, not MacNamara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Miscarriage Associated with Zika Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

An update on Zika virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

The 3.8 Å resolution cryo-EM structure of Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Vaccine protection against Zika virus from Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Structural Basis of Zika Virus-Specific Antibody Protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

A Single Injection of Human Neutralizing Antibody Protects against Zika Virus Infection and Microcephaly in Developing Mouse Embryos.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Human antibody response to Zika targets type-specific quaternary structure epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Development of vaccines against Zika virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Immunization with truncated envelope protein of Zika virus induces protective immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Rapid development of a DNA vaccine for Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Rapid travel to a Zika vaccine: are we heading towards success or more questions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

DNA vaccines: ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Revealing the role of CD4(+) T cells in viral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Vaccine adjuvant uses of poly-IC and derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

DNA vaccination protects mice against Zika virus-induced damage to the testes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

A rhesus macaque model of Asian-lineage Zika virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Cross-reactive Dengue virus-specific CD8 T cells protect against Zika virus during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Critical role of CD4 T cells and IFNγ signaling in antibody-mediated resistance to Zika virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Human T cell responses to Japanese encephalitis virus in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.03.037

10.1016/J.VACCINE.2020.03.037

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32247567%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference